ATC Group: A04AA05 Palonosetron

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Antiemetics and antinauseants
3
Antiemetics and antinauseants
4
Serotonin (5HT3) antagonists
5
A04AA05
Palonosetron

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.5 mg
PAREN - Parenteral
0.25 mg

Active ingredients

Active Ingredient
Description

Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.

Medicines in this ATC group

Drug
Countries

Australia Austria Canada Cyprus Estonia ...

South Africa

Cyprus Estonia Lithuania Spain

South Africa

Brazil New Zealand South Africa

South Africa

South Africa

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
Summary of Product Characteristics (SPC)
Medication Package Insert (MPI)
ZA